project id: TCGA-STAD; case submitter id: TCGA-IN-A7NT; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.97; rna integrity number: 7.7; age at index: 73; days to birth: -26727; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 26727; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 323.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 86; initial weight: 210.0; sample id: 3097a891-3611-4ace-b2cf-4b6b18df6385; sample submitter id: TCGA-IN-A7NT-01A; portion id: c1cf7e8a-5f70-48a4-a76c-ed21fe9c54c2; portion submitter id: TCGA-IN-A7NT-01A-21; slide id: 59ccf4b3-51a5-48f0-9c84-101169c6770d; slide submitter id: TCGA-IN-A7NT-01A-02-TSB; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;